Metabolic reprogramming driven by EZH2 inhibition depends on cell–matrix interactions
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2023.105485 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Teresa W-M Fan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Environmental and System Biochemistry, University of Kentucky, Lexington, Kentucky, USA; Department of Toxicology and Cancer Biology, Univ…. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Metabolic Reprogramming. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, American Cancer Society.
Abstract (Originalsprache)
EZH2 (Enhancer of Zeste Homolog 2), a subunit of Polycomb Repressive Complex 2 (PRC2), catalyzes the trimethylation of histone H3 at lysine 27 (H3K27me3), which represses expression of genes. It also has PRC2-independent functions, including transcriptional coactivation of oncogenes, and is frequently overexpressed in lung cancers. Clinically, EZH2 inhibition can be achieved with the FDA-approved drug EPZ-6438 (tazemetostat). To realize the full potential of EZH2 blockade, it is critical to understand how cell-cell/cell-matrix interactions present in 3D tissue and cell culture systems influences this blockade in terms of growth-related metabolic functions. Here, we show that EZH2 suppression reduced growth of human lung adenocarcinoma A549 cells in 2D cultures but stimulated growth in 3D cultures. To understand the metabolic underpinnings, we employed [13C6]-glucose stable isotope-resolved metabolomics to determine the effect of EZH2 suppression on metabolic networks in 2D versus 3D A549 cultures. The Krebs cycle, neoribogenesis, γ-aminobutyrate metabolism, and salvage synthesis of purine nucleotides were activated by EZH2 suppression in 3D spheroids but not in 2D cells, consistent with the growth effect. Using simultaneous 2H7-glucose + 13C5,15N2-Gln tracers and EPZ-6438 inhibition of H3 trimethylation, we delineated the effects on the Krebs cycle, γ-aminobutyrate metabolism, gluconeogenesis, and purine salvage to be PRC2-dependent. Furthermore, the growth/metabolic effects differed for mouse Matrigel versus self-produced A549 extracellular matrix. Thus, our findings highlight the importance of the presence and nature of extracellular matrix in studying the function of EZH2 and its inhibitors in cancer cells for modeling the in vivo outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Environmental and System Biochemistry, University of Kentucky, Lexington, Kentucky, USA; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA; Markey Cancer Center, Un…
- Center for Environmental and System Biochemistry, University of Kentucky, Lexington, Kentucky, USA.
- Center for Environmental and System Biochemistry, University of Kentucky, Lexington, Kentucky, USA; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
- Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky, USA; Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- American Cancer Society
- University of Kentucky
- National Institutes of Health
Zitieren
APA
W-M Fan, T., Islam, J. M. M., Higashi, R. M., Lin, P., Brainson, C. F., & Lane, A. N. (2024). Metabolic reprogramming driven by EZH2 inhibition depends on cell–matrix interactions. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.105485
Vancouver
W-M Fan T, Islam JMM, Higashi RM, Lin P, Brainson CF, Lane AN. Metabolic reprogramming driven by EZH2 inhibition depends on cell–matrix interactions. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2023.105485
BibTeX
@article{WMFan2024,
author = {W-M Fan, Teresa and Islam, Jahid M M and Higashi, Richard M and Lin, Penghui and Brainson, Christine F and Lane, Andrew N},
title = {Metabolic reprogramming driven by EZH2 inhibition depends on cell–matrix interactions},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2023.105485}
}
EUVIMED